
PROCEPT BioRobotics (PRCT) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
PROCEPT BioRobotics (PRCT) last issued guidance on August 4, 2026 for fiscal year 2026. The company guided revenue in the range of $390M - $410M for the period.
Compared to prior guidance, PROCEPT BioRobotics maintained its revenue forecast from a prior range of $390M - $410M.
PROCEPT BioRobotics has issued 25 guidance updates between November 3, 2022 and August 4, 2026. During this period, the company raised its outlook 12 times and lowered it 7 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.46 | $-0.56 | $-0.32 | $-0.42 |
| Actual | $-0.47 | $-0.56 | $-0.53 | $-0.38 |
| Surprise | -2.17% | 0.00% | -65.6% | +9.52% |
| Revenue | ||||
| Estimate | $92.8M | $80.5M | $93.7M | $80.7M |
| Actual | $94.5M | $83.1M | $76.4M | $83.3M |
| Surprise | +1.88% | +3.28% | -18.5% | +3.24% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.39 | $-0.25 | $-0.37 | $-0.31 |
| Revenue | ||||
| Consensus | $100.9M | $117.7M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 4, 2026 | $-0.47 | $-0.46 | -2.17 % |
| Q1 | Apr 29, 2026 | $-0.56 | $-0.56 | 0.00 % |
| Q4 | Feb 25, 2026 | $-0.53 | $-0.32 | -65.6 % |
| Q3 | Nov 4, 2025 | $-0.38 | $-0.42 | 9.52 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 4, 2026 | $94.50M | $92.76M | 1.88 % |
| Q1 | Apr 29, 2026 | $83.13M | $80.50M | 3.28 % |
| Q4 | Feb 25, 2026 | $76.38M | $93.70M | -18.5 % |
| Q3 | Nov 4, 2025 | $83.33M | $80.71M | 3.24 % |